0000000000098164

AUTHOR

Salvatore Cammarieri

Mutation in beta-fibrinogen gene (C148T) is important risk factor in patients affected by thromboembolic disease.

research product

Methionine synthase polymorphism A2756G and its association with thromboembolic disease

research product

Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase MTHFR A1298C gene polymorphism in subjects affected by thromboembolic disease

research product

Genetic variants beta-fibrinogen gene, especially G-455-A polymorphism, in patients with thromboembolic disease.

research product

C677T and A1298C polymorphism of the methylentetrahydrofolate reductase gene: a risk factor for arterial disease and venous thrombosis

research product

Factor V Leiden, Prothrombin G20210A mutations are risk factors for deep vein thrombosis

research product

Association between angiotensin I - converting enzyme gene insertion/deletion polymorphism and thromboembolic disease.

research product

Vitamin E and vitamin A plasma levels in patients with Mild Cognitive Impairent (MCI)

research product

Homocysteine and MTHFR gene polimorphysms in patients with venous tromboembolic disease

research product

Apo E polymorphism as risk factor for cardiovascular diseases in Sicilian subjects.

research product

Plasminogen Activator Inhibitor-1 -675 4G/5G and Methylenetetrahydrofolate reductase gene variants in young acute myocardial infarction and juvenile ischemic stroke

research product

Prevalence and association of the Factor V Leiden and Prothrombin G20210A in healthy subjects and patients with venous tromboembolism

research product

Mutations in Factor V Leiden (G1691A) and Prothrombin (G2021A) genes are important risk factors for venous thromboembolism

research product

Apoliprotein E gene polymorphism in subjects affected by cardiovascular disease in Sicilian populations

research product

Hyperhomocysteinemia and methylenetetrahydrofolare reductase 677C→T and 1298A→C mutations in patients with venous thromboembolic disease

research product

The risk of cardiovascular events is reduced by lowering hyperhomocysteinemia short term B vitamins therapy

research product